• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在E848G肥厚型心肌病干细胞模型中,心肌细胞凋亡导致收缩功能障碍。

Cardiomyocyte apoptosis contributes to contractile dysfunction in stem cell model of E848G hypertrophic cardiomyopathy.

作者信息

Loiben Alexander M, Chien Wei-Ming, Friedman Clayton E, Chao Leslie S-L, Weber Gerhard, Goldstein Alex, Sniadecki Nathan, Murry Charles E, Yang Kai-Chun

机构信息

Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA, USA.

Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA.

出版信息

bioRxiv. 2023 Jan 25:2023.01.24.525458. doi: 10.1101/2023.01.24.525458.

DOI:10.1101/2023.01.24.525458
PMID:36747800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9900838/
Abstract

Missense mutations in myosin heavy chain 7 ( ) are a common cause of hyper-trophic cardiomyopathy (HCM), but the molecular mechanisms underlying -based HCM remain unclear. In this work, we generated cardiomyocytes derived from isogenic human induced pluripotent stem cells to model the heterozygous pathogenic missense variant, E848G, which is associated with left ventricular hypertrophy and adultonset systolic dysfunction. increased cardiomyocyte size and reduced the maximum twitch forces of engineered heart tissue, consistent with the systolic dysfunction in E848G HCM patients. Interestingly, cardiomyocytes more frequently underwent apoptosis that was associated with increased p53 activity relative to controls. However, genetic ablation of did not rescue cardiomyocyte survival or restore engineered heart tissue twitch force, indicating cardiomyocyte apoptosis and contractile dysfunction are p53-independent. Overall, our findings suggest that cardiomyocyte apoptosis plays an important role in the HCM phenotype and that future efforts to target p53-independent cell death pathways may be beneficial for the treatment of HCM patients with systolic dysfunction.

摘要

肌球蛋白重链7( )中的错义突变是肥厚型心肌病(HCM)的常见病因,但基于 的HCM潜在分子机制仍不清楚。在这项研究中,我们从同基因人诱导多能干细胞中生成心肌细胞,以模拟杂合致病性错义变体E848G,该变体与左心室肥厚和成人发病的收缩功能障碍有关。 增加了心肌细胞大小,并降低了工程化心脏组织的最大收缩力,这与E848G HCM患者的收缩功能障碍一致。有趣的是,与对照相比, 心肌细胞更频繁地发生凋亡,这与p53活性增加有关。然而, 的基因敲除并未挽救心肌细胞存活或恢复工程化心脏组织的收缩力,表明 心肌细胞凋亡和收缩功能障碍是p53非依赖性的。总体而言,我们的研究结果表明,心肌细胞凋亡在 HCM表型中起重要作用,未来针对p53非依赖性细胞死亡途径的努力可能对治疗有收缩功能障碍的HCM患者有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/ce3a5aae211c/nihpp-2023.01.24.525458v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/dee825d6a3e1/nihpp-2023.01.24.525458v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/5797c742aec7/nihpp-2023.01.24.525458v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/833f384980b2/nihpp-2023.01.24.525458v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/ce3a5aae211c/nihpp-2023.01.24.525458v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/dee825d6a3e1/nihpp-2023.01.24.525458v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/5797c742aec7/nihpp-2023.01.24.525458v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/833f384980b2/nihpp-2023.01.24.525458v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f4/9900838/ce3a5aae211c/nihpp-2023.01.24.525458v1-f0004.jpg

相似文献

1
Cardiomyocyte apoptosis contributes to contractile dysfunction in stem cell model of E848G hypertrophic cardiomyopathy.在E848G肥厚型心肌病干细胞模型中,心肌细胞凋亡导致收缩功能障碍。
bioRxiv. 2023 Jan 25:2023.01.24.525458. doi: 10.1101/2023.01.24.525458.
2
Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of E848G Hypertrophic Cardiomyopathy.心肌细胞凋亡与 E848G 肥厚型心肌病干细胞模型中的收缩功能障碍有关。
Int J Mol Sci. 2023 Mar 3;24(5):4909. doi: 10.3390/ijms24054909.
3
Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells.患者来源的诱导多能干细胞中 MYH7 E848G 突变导致的新型成人起病型收缩性心肌病
JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740. doi: 10.1016/j.jacbts.2018.08.008. eCollection 2018 Dec.
4
Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.MYH7 基因突变诱导多能干细胞衍生的心肌细胞中增强的肌球蛋白细丝钙敏感性加重异常钙处理和舒张功能障碍。
Cell Calcium. 2024 Jan;117:102822. doi: 10.1016/j.ceca.2023.102822. Epub 2023 Nov 8.
5
Burst-Like Transcription of Mutant and Wildtype -Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy.突变型和野生型等位基因的爆发式转录可能是肥厚型心肌病细胞间收缩失衡的起源。
Front Physiol. 2018 Apr 9;9:359. doi: 10.3389/fphys.2018.00359. eCollection 2018.
6
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy.MYBPC3 相关肥厚型心肌病与 MYH7 相关肥厚型心肌病患者的收缩功能障碍长期患病率。
Circ Genom Precis Med. 2023 Aug;16(4):363-371. doi: 10.1161/CIRCGEN.122.003832. Epub 2023 Jul 6.
7
Multiplexed Functional Assessments of Variants in Human Cardiomyocytes.高通量功能性评估人类心肌细胞中的变异。
Circ Genom Precis Med. 2024 Apr;17(2):e004377. doi: 10.1161/CIRCGEN.123.004377. Epub 2024 Feb 16.
8
Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.肌 LIM 蛋白力感介导人类家族性肥厚型心肌病中的肌节生物力学信号转导。
Circulation. 2022 Apr 19;145(16):1238-1253. doi: 10.1161/CIRCULATIONAHA.121.056265. Epub 2022 Apr 6.
9
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.抑制心脏髓过氧化物酶可减轻肥厚型心肌细胞的舒张功能障碍。
Cardiovasc Res. 2022 Jan 29;118(2):517-530. doi: 10.1093/cvr/cvab077.
10
Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.肥厚型心肌病功能障碍在人源工程心脏组织中得到模拟,并通过钠-葡萄糖共转运蛋白 2 抑制剂得到改善。
Cardiovasc Res. 2024 Mar 14;120(3):301-317. doi: 10.1093/cvr/cvae004.

本文引用的文献

1
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM):一项随机、双盲、安慰剂对照、3 期临床试验的健康状况分析。
Lancet. 2021 Jun 26;397(10293):2467-2475. doi: 10.1016/S0140-6736(21)00763-7. Epub 2021 May 15.
2
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
3
Effect of p53 activation on experimental right ventricular hypertrophy.p53 激活对实验性右心室肥厚的影响。
PLoS One. 2020 Jun 19;15(6):e0234872. doi: 10.1371/journal.pone.0234872. eCollection 2020.
4
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.肥厚型心肌病的同基因模型揭示了不同的表型和机制驱动的治疗方法。
J Mol Cell Cardiol. 2020 Aug;145:43-53. doi: 10.1016/j.yjmcc.2020.06.003. Epub 2020 Jun 10.
5
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.肥厚型心肌病伴左心室收缩功能障碍:来自 SHaRe 注册研究的见解。
Circulation. 2020 Apr 28;141(17):1371-1383. doi: 10.1161/CIRCULATIONAHA.119.044366. Epub 2020 Mar 31.
6
Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload.工程化心肌微组织由于 MYBPC3 缺乏和机械超负荷导致的收缩功能障碍。
Nat Biomed Eng. 2018 Dec;2(12):955-967. doi: 10.1038/s41551-018-0280-4. Epub 2018 Sep 10.
7
Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells.患者来源的诱导多能干细胞中 MYH7 E848G 突变导致的新型成人起病型收缩性心肌病
JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740. doi: 10.1016/j.jacbts.2018.08.008. eCollection 2018 Dec.
8
A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations.肌节突变致肥厚型心肌病的收缩应激模型。
Stem Cell Reports. 2019 Jan 8;12(1):71-83. doi: 10.1016/j.stemcr.2018.11.015. Epub 2018 Dec 13.
9
The genetics of hypertrophic cardiomyopathy.肥厚型心肌病的遗传学
Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):36. doi: 10.21542/gcsp.2018.36.
10
Loss of P53 regresses cardiac remodeling induced by pressure overload partially through inhibiting HIF1α signaling in mice.失活 P53 部分通过抑制 HIF1α 信号通路逆转压力超负荷诱导的心肌重构
Biochem Biophys Res Commun. 2018 Jun 22;501(2):394-399. doi: 10.1016/j.bbrc.2018.04.225. Epub 2018 May 11.